Registry for patients with spontaneous intracranial hypotension
Official title: Spontaneous Intracranial Hypotension Registry
Run by Mayo Clinic · NCT05922514 · Data updated 2026-11-12
This study is trying to see if a treatment called paraspinal vein embolization can help people with spontaneous intracranial hypotension who have specific fluid leaks in their brain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | June 18, 2023 |
| Main results expected | July 2028 |
| Study ends | December 2028 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT05922514 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed with SIH who have imaging-confirmed CSF-venous fistulas.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have contraindications to the procedure will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on patients diagnosed with spontaneous intracranial hypotension (SIH) who have confirmed cerebrospinal fluid-venous fistulas. By utilizing imaging techniques such as digital subtraction myelography (DSM) and CT myelography (CTM), the study seeks to assess the efficacy of paraspinal vein embolization as a treatment option. The findings will help inform the design of future clinical trials targeting this condition. Participants will be monitored for their responses and outcomes over a specified follow-up period.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients suffering from spontaneous intracranial hypotension.
How similar studies have gone: While this approach is being explored, the efficacy of paraspinal vein embolization for SIH has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Study subjects will be patients who meet the International Classification of Headache - Disorders 3rd Edition (ICHD-3) criteria for a diagnosis of SIH or the Schievink criteria with imaging confirmed CSF-venous fistulas on DSM or CTM. * Availability of a clinically prescribed contrast enhanced MRI positive for SIH. * Negative urine or serum pregnancy test at time of study consent and three-months. Exclusion Criteria: * Patients who have a contraindication or inability to undergo the procedure (i.e., severe contrast allergy). * Inability to provide informed consent. * Expected inability to complete the follow-up assessment. * Current pregnancy or breast-feeding during study enrollment (from consent to study conclusion approximately 90-days).
Where it's running
-
Mayo Clinic Minnesota
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Waleed Brinjikji, MD — Mayo Clinic
- Study coordinator: Gerard El Hajj, M.D.
- Email: ElHajj.Gerard@mayo.edu
- Phone: 507-255-2860
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing two CT myelography methods for detecting CSF-venous fistulas in SIH
This study tests whether the photon counting detector CT myelography (PCD-CTM) can find CSF-venous fistulas in spontaneous intracranial hypotension patients better than the standard energy integrating detector CT myelography (EID-CTM).
-
Greater occipital nerve block to relieve headaches from spontaneous intracranial hypotension
This will try a bilateral ultrasound-guided greater occipital nerve block in adults with spontaneous intracranial hypotension to see if it quickly reduces upright headache.
-
Catheter ablation for AF after spontaneous intracranial hemorrhage: SAFER-AF
This study tests whether catheter ablation can offer better long-term outcomes than usual care for adults with atrial fibrillation who recently had a spontaneous intracranial hemorrhage.
-
AI-guided robotic minimally invasive neurosurgery for intracerebral hemorrhage (RAINBOW-ICH)
This trial will test whether AI-assisted, robotic-guided minimally invasive surgery helps adults with spontaneous intracerebral hemorrhage (including basal ganglia, intraventricular, and brainstem types) recover better than conventional care.
-
Evaluating emergency surgery for severe brain hemorrhage patients on long-term antiplatelet treatment
This study is trying to see if emergency surgery can help people with severe brain bleeding who are taking blood-thinning medications and how safe it is for them.
-
Comparing stent implantation to medical therapy for idiopathic intracranial hypertension
This study is testing whether putting in a stent helps people with idiopathic intracranial hypertension feel better compared to just using medication.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.